A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

NCT04882878 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

OTHER: Placebo
DRUG: Nipocalimab
DRUG: Standard-of-care treatment

Sponsor

Janssen Research & Development, LLC